Similar articles

• Novel naphthalenedisulfonic acid anti-HIV-1 agents. Synthesis and activity against reverse transcriptase, virus replication and syncytia formation.

  Mohan P, Singh R, Baba M. Mohan P, et al. Drug Des Discov. 1991 Nov;8(1):69-82. Drug Des Discov. 1991. PMID: 1725723
• Interaction of an anti-HIV peptide, T22, with gp120 and CD4.

  Tamamura H, Otaka A, Murakami T, Ishihara T, Ibuka T, Waki M, Matsumoto A, Yamamoto N, Fujii N. Tamamura H, et al. Biochem Biophys Res Commun. 1996 Feb 15;219(2):555-9. doi: 10.1006/bbrc.1996.0272. Biochem Biophys Res Commun. 1996. PMID: 8605026
• Anti-HIV-1 and HIV-2 activity of naphthalenedisulfonic acid derivatives. Inhibition of cytopathogenesis, giant cell formation, and reverse transcriptase activity.

  Mohan P, Singh R, Baba M. Mohan P, et al. Biochem Pharmacol. 1991 Feb 15;41(4):642-6. doi: 10.1016/0006-2952(91)90641-h. Biochem Pharmacol. 1991. PMID: 1705124 No abstract available.
• Inhibition of HIV-1 entry: multiple keys to close the door.

  Hertje M, Zhou M, Dietrich U. Hertje M, et al. ChemMedChem. 2010 Nov 8;5(11):1825-35. doi: 10.1002/cmdc.201000292. ChemMedChem. 2010. PMID: 20845361 Review. No abstract available.
• [Polyoxometalate "PM-104" as anti-HIV agent].

  Inouye Y, Yoshida T. Inouye Y, et al. Nihon Rinsho. 1993 Sep;51 Suppl:186-91. Nihon Rinsho. 1993. PMID: 8271383 Review. Japanese. No abstract available.